An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer

Abstract Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by Adenosine DeAminases acting on double-stranded RNA(dsRNA) (ADAR), occurs predominantly in the 3′ untranslated regions (3′UTRs) of spliced mRNA. Here we uncover an unanticipated link between ADARs (ADAR1 and ADAR2) and the expression of target genes undergoing extensive 3′UTR editing. Using METTL7A (Methyltransferase Like 7A), a novel tumor suppressor gene with multiple editing sites at its 3′UTR, we demonstrate that its expression could be repressed by ADARs beyond their RNA editing and double-stranded RNA (dsRNA) binding functions. ADARs interact with Dicer to augment the processing of pre-miR-27a to mature miR-27a. Consequently, mature miR-27a targets the METTL7A 3′UTR to repress its expression level. In sum, our study unveils that the extensive 3′UTR editing of METTL7A is merely a footprint of ADAR binding, and there are a subset of target genes that are equivalently regulated by ADAR1 and ADAR2 through their non-canonical RNA editing and dsRNA binding-independent functions, albeit maybe less common. The functional significance of ADARs is much more diverse than previously appreciated and this gene regulatory function of ADARs is most likely to be of high biological importance beyond the best-studied editing function. This non-editing side of ADARs opens another door to target cancer.

[1]  Yuan Yuan,et al.  MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori , 2017, Scientific Reports.

[2]  Deepak K. Singh,et al.  ADAR2 regulates RNA stability by modifying access of decay-promoting RNA-binding proteins , 2017, Nucleic acids research.

[3]  Cory C. Funk,et al.  Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development. , 2015, Immunity.

[4]  R. Lockey,et al.  Detection of canonical A-to-G editing events at 3′ UTRs and microRNA target sites in human lungs using next-generation sequencing , 2015, Oncotarget.

[5]  Eli Eisenberg,et al.  Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors. , 2015, Cell reports.

[6]  P. Seeburg,et al.  RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself , 2015, Science.

[7]  Honglin Hu,et al.  rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression. , 2015, Biochemical and biophysical research communications.

[8]  Gianluigi Giannelli,et al.  Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study , 2015, Gut.

[9]  Xinshu Xiao,et al.  Genomic Analysis of ADAR1 Binding and its Involvement in Multiple RNA Processing Pathways , 2015, Nature Communications.

[10]  A. Guo,et al.  The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. , 2015, Molecular bioSystems.

[11]  Chris P. Ponting,et al.  The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA , 2014, Cell reports.

[12]  Seung-Yong Jeong,et al.  RNA editing in RHOQ promotes invasion potential in colorectal cancer , 2014, The Journal of experimental medicine.

[13]  D. Tenen,et al.  RNA editome imbalance in hepatocellular carcinoma. , 2014, Cancer research.

[14]  Gene W. Yeo,et al.  The dsRBP and inactive editor ADR-1 utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome. , 2014, Cell reports.

[15]  Yanhong Tai,et al.  ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding , 2013, RNA.

[16]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[17]  R. Xing,et al.  MiR‐23a in amplified 19p13.13 loci targets metallothionein 2A and promotes growth in gastric cancer cells , 2013, Journal of cellular biochemistry.

[18]  K. Nishikura,et al.  Human endonuclease V is a ribonuclease specific for inosine-containing RNA , 2013, Nature Communications.

[19]  Kol Jia Yong,et al.  A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma , 2013, Gut.

[20]  Ramana V. Davuluri,et al.  ADAR1 Forms a Complex with Dicer to Promote MicroRNA Processing and RNA-Induced Gene Silencing , 2013, Cell.

[21]  G. Wahl,et al.  MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.

[22]  Leilei Chen,et al.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.

[23]  R. Boldrini,et al.  ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis , 2012, Oncogene.

[24]  Wenwei Zhang,et al.  Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome , 2012, Nature Biotechnology.

[25]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[26]  Juan Wang,et al.  The expression of TIPE1 in murine tissues and human cell lines. , 2011, Molecular immunology.

[27]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[28]  A. Hatzigeorgiou,et al.  Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency* , 2010, The Journal of Biological Chemistry.

[29]  Asaf Levy,et al.  Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high‐risk women , 2010, International journal of cancer.

[30]  K. Nishikura.  Functions and regulation of RNA editing by ADAR deaminases. , 2010, Annual review of biochemistry.

[31]  S. Safe,et al.  MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. , 2010, Endocrinology.

[32]  S. Maas,et al.  Molecular diversity through RNA editing: a balancing act. , 2010, Trends in genetics : TIG.

[33]  D. Tarin,et al.  RBBP9: A tumor-associated serine hydrolase activity required for pancreatic neoplasia , 2009, Proceedings of the National Academy of Sciences.

[34]  Yi Xing,et al.  Adenosine deamination in human transcripts generates novel microRNA binding sites , 2009, Human molecular genetics.

[35]  M. O’Connell,et al.  Editing independent effects of ADARs on the miRNA/siRNA pathways , 2009, The EMBO journal.

[36]  Kiyoshi Asai,et al.  CentroidFold: a web server for RNA secondary structure prediction , 2009, Nucleic Acids Res..

[37]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[38]  Izumi V. Hinkson,et al.  RNA Editing of Androgen Receptor Gene Transcripts in Prostate Cancer Cells* , 2008, Journal of Biological Chemistry.

[39]  B. Bass,et al.  C. elegans and H. sapiens mRNAs with edited 3' UTRs are present on polysomes. , 2008, RNA.

[40]  Molly Megraw,et al.  Frequency and fate of microRNA editing in human brain , 2008, Nucleic acids research.

[41]  Richard G. W. Anderson,et al.  Identification of a novel N-terminal hydrophobic sequence that targets proteins to lipid droplets , 2008, Journal of Cell Science.

[42]  M. O’Connell,et al.  Down-regulation of RNA Editing in Pediatric Astrocytomas , 2008, Journal of Biological Chemistry.

[43]  Yukio Kawahara,et al.  RNA editing of the microRNA‐151 precursor blocks cleavage by the Dicer–TRBP complex , 2007, EMBO reports.

[44]  K. Nishikura,et al.  RNA Binding-independent Dimerization of Adenosine Deaminases Acting on RNA and Dominant Negative Effects of Nonfunctional Subunits on Dimer Functions* , 2007, Journal of Biological Chemistry.

[45]  A. Hatzigeorgiou,et al.  Redirection of Silencing Targets by Adenosine-to-Inosine Editing of miRNAs , 2007, Science.

[46]  K. Nishikura,et al.  Editor meets silencer: crosstalk between RNA editing and RNA interference , 2006, Nature Reviews Molecular Cell Biology.

[47]  F. Nielsen,et al.  Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. , 2006, RNA.

[48]  A. MacMillan,et al.  FRET Analysis of in Vivo Dimerization by RNA-editing Enzymes* , 2006, Journal of Biological Chemistry.

[49]  P. M. Nissom,et al.  A novel normalization method for effective removal of systematic variation in microarray data , 2006, Nucleic acids research.

[50]  Michael Q. Zhang,et al.  Regulating Gene Expression through RNA Nuclear Retention , 2005, Cell.

[51]  P. Kao,et al.  ADAR1 Interacts with NF90 through Double-Stranded RNA and Regulates NF90-Mediated Gene Expression Independently of RNA Editing , 2005, Molecular and Cellular Biology.

[52]  A. Scadden.  The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage , 2005, Nature Structural &Molecular Biology.

[53]  Richard Wooster,et al.  A survey of RNA editing in human brain. , 2004, Genome research.

[54]  Alexander Rich,et al.  Widespread A-to-I RNA Editing of Alu-Containing mRNAs in the Human Transcriptome , 2004, PLoS biology.

[55]  Brenda L Bass,et al.  Mutations in RNAi Rescue Aberrant Chemotaxis of ADAR Mutants , 2003, Science.

[56]  B. Bass,et al.  RNA editing by ADARs is important for normal behavior in Caenorhabditis elegans , 2002, The EMBO journal.

[57]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[58]  Zuo Zhang,et al.  The Fate of dsRNA in the Nucleus A p54nrb-Containing Complex Mediates the Nuclear Retention of Promiscuously A-to-I Edited RNAs , 2001, Cell.

[59]  D. Feldmeyer,et al.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2 , 2000, Nature.

[60]  R. Reenan,et al.  dADAR, a Drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing. , 2000, RNA.

[61]  K. Nishikura,et al.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. , 2000, RNA.

[62]  S. Thorgeirsson,et al.  A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability , 1998, Nature Genetics.

[63]  P. Seeburg,et al.  RED2, a Brain-specific Member of the RNA-specific Adenosine Deaminase Family* , 1996, The Journal of Biological Chemistry.

[64]  K. Nishikura,et al.  Mutagenic Analysis of Double-stranded RNA Adenosine Deaminase, a Candidate Enzyme for RNA Editing of Glutamate-gated Ion Channel Transcripts (*) , 1995, The Journal of Biological Chemistry.

[65]  J. E. Smith,et al.  A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Brenda L. Bass,et al.  An unwinding activity that covalently modifies its double-stranded RNA substrate , 1988, Cell.

[67]  Jun Li,et al.  MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway. , 2017, American journal of cancer research.

[68]  D. Sarkar.  AEG-1/MTDH/LYRIC in liver cancer. , 2013, Advances in cancer research.

[69]  P. Seeburg,et al.  Modulation of microRNA processing and expression through RNA editing by ADAR deaminases , 2006, Nature Structural &Molecular Biology.

[70]  A. Scadden,et al.  RNAi is antagonized by A-->I hyper-editing. , 2001, EMBO reports.